Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 793-800 , October 2008

Labelling and biological evaluation of [11C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor

  • Nele Evens

      Affiliations

    • Laboratory for Radiopharmacy, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Barbara Bosier

      Affiliations

    • Department of Pharmaceutical Chemistry and Radiopharmacy, U.C.L., Brussels 1200, Belgium
    • ,
  • Brian J. Lavey

      Affiliations

    • Schering Plough Research Institute, Kenilworth, NJ 07033, USA
    • ,
  • Joseph A. Kozlowski

      Affiliations

    • Schering Plough Research Institute, Kenilworth, NJ 07033, USA
    • ,
  • Peter Vermaelen

      Affiliations

    • Division of Nuclear Medicine, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Luc Baudemprez

      Affiliations

    • Laboratory of Medicinal Chemistry, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Roger Busson

      Affiliations

    • Laboratory of Medicinal Chemistry, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Didier M. Lambert

      Affiliations

    • Department of Pharmaceutical Chemistry and Radiopharmacy, U.C.L., Brussels 1200, Belgium
    • ,
  • Koen Van Laere

      Affiliations

    • Division of Nuclear Medicine, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Alfons M. Verbruggen

      Affiliations

    • Laboratory for Radiopharmacy, K.U.Leuven, Leuven 3000, Belgium
    • ,
  • Guy M. Bormans

      Affiliations

    • Laboratory for Radiopharmacy, K.U.Leuven, Leuven 3000, Belgium
    • Corresponding Author InformationCorresponding author. Onderwijs & Navorsing 2, Herestraat 49, bus 821, BE-3000 Leuven, Belgium. Tel.: +32 16 330447; fax: +32 16 330449.

Received 4 June 2008 ,Revised 3 July 2008 ,Accepted 10 July 2008.

References 

  1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561–564
  2. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor of cannabinoids. Nature. 1993;365:61–65
  3. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Ming FM, et al. Evidence for novel cannabinoid receptors. Pharmacol Ther. 2005;106:133–145
  4. Lynn AB, Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther. 1994;268:1612–1623
  5. Ashton JC, Friberg D, Darlington CL, Smith PF. Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett. 2006;396:113–116
  6. Gong J, Onaivi ES, Ishiguro H, Liu Q, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006;1071:10–23
  7. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329–332
  8. Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem. 2005;95:437–445
  9. Ellert-Miklaszewska A, Grajkowska W, Gabrusiewicz K, Kaminska B, Konarska L. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors. Brain Res. 2007;1137:161–169
  10. Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature. 2005;434:782–786
  11. Ramirez BG. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci. 2005;25:1904–1913
  12. Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci. 2007;27:2396–2402
  13. Pertwee R. Cannabinoids and multiple sclerosis. Pharmacol Ther. 2002;95:165–174
  14. Sugiura T, Oka S, Gokoh M, Kishimoto S, Waku K. New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. J Pharmacol Sci. 2004;96:367–375
  15. Gutierrez T, Farthing JN, Zyonok AM, Makriyannis A, Hohmann AG. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol. 2007;150:153–163
  16. Herrera B, Carracedo A, Diez-Zaera M, Guzman M, Velasco G. p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. FEBS Lett. 2005;579:5084–5088
  17. Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G, et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 2006;20:2633–2635
  18. Gonsiorek W, Hesk D, Kinsley D, Chen SC, Fine JS, Jackson JV, et al. Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336. J Biol Chem. 2006;281:43–51
  19. Bai M, Sexton M, Stella N, Bornhop DJ. MBC94, a conjugable ligand for cannabinoid CB2 receptor imaging. Bioconjug Chem. 2008;19:988–992
  20. Lavey BJ, Kozlowski JA, Hipkin RW, Gonsiored W, Lundell DJ, Piwinski JJ, et al. Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies. Bioorg Med Chem Lett. 2005;15:783–786
  21. Shankar BB, Lavey BJ, Zhou G, Spitler JA, Tong L, Rizvi R, et al. Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies. Bioorg Med Chem Lett. 2005;15:4417–4420
  22. Larsen P, Ulin J, Dahlstrom K, Jensen M. Synthesis of [C-11]iodomethane by iodination of [C-11]methane. Appl Radiat Isotopes. 1997;48:153–157
  23. Bradford MM. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  24. Muccioli GG, Wouters J, Charlier C, Scriba GK, Pizza T, Di Pace P, et al. Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists. J Med Chem. 2006;49:872–882
  25. Cheng YC, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099–3108
  26. Chitneni SK, Serdons K, Evens N, Fonge H, Celen S, Deroose CM, et al. Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction. J Chromatogr A. 2008;1189:323–331
  27. McOmie JFW, Watts ML, West DE. Demethylation of aryl methyl ethers by boron tribromide. Tetrahedron Lett. 1968;24:2289–2292
  28. Dishino DD, Welch MJ, Kilbourn MR, Raichle ME. Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med. 1983;24:1030–1038
  29. Verbist BM, De Cleyn MA, Surkyn M, Fraiponts E, Aerssens J, Nijsen MJ, et al. 5-Sulfonyl-benzimidazoles as selective CB2 agonists. Bioorg Med Chem Lett. 2008;18:2574–2579
  30. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43:3714–3717
  31. Van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J Drug Target. 1998;6:151–165
  32. Govaerts JG, Hermans E, Lambert DM. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur J Pharm Sci. 2004;23:233–243
  33. Lunn CA, Fine JS, Rojas-Triana A, Jackson JV, Fan X, Kung TT, et al. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leucocyte recruitment in vivo. J Pharmacol Exp Ther. 2006;316:780–788
  34. Kozlowski JA, Shih N-Y, Lavey BJ, Rizvi RK, Shankar BP, Spitler JM, et al. World Patent WO02062750 2002.

PII: S0969-8051(08)00173-X

doi: 10.1016/j.nucmedbio.2008.07.004

Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 793-800 , October 2008

Article Tools

* Image Usage & Resolution